Tredje AP-fonden’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
5,186
+506
| +11% | +$145K | 0.01% | 290 |
|
|
2025
Q1 | $1.44M | Hold |
4,680
| – | – | 0.01% | 281 |
|
|
2024
Q4 | $1.65M | Sell |
4,680
-4,679
| -50% | -$1.65M | 0.01% | 305 |
|
|
2024
Q3 | $3.35M | Hold |
9,359
| – | – | 0.03% | 265 |
|
|
2024
Q2 | $2.98M | Sell |
9,359
-142
| -1% | -$45.2K | 0.03% | 269 |
|
|
2024
Q1 | $2.18M | Buy |
9,501
+2,071
| +28% | +$476K | 0.02% | 346 |
|
|
2023
Q4 | $1.63M | Sell |
7,430
-332
| -4% | -$73K | 0.02% | 418 |
|
|
2023
Q3 | $1.75M | Sell |
7,762
-595
| -7% | -$134K | 0.03% | 395 |
|
|
2023
Q2 | $1.84M | Sell |
8,357
-1,307
| -14% | -$289K | 0.03% | 402 |
|
|
2023
Q1 | $2.16M | Buy |
+9,664
| New | +$2.16M | 0.03% | 375 |
|
|
2017
Q4 | – | Sell |
-4,060
| Closed | -$476K | – | 584 |
|
|
2017
Q3 | $476K | Sell |
4,060
-8,040
| -66% | -$943K | 0.02% | 504 |
|
|
2017
Q2 | $1.57M | Buy |
12,100
+4,350
| +56% | +$564K | 0.06% | 357 |
|
|
2017
Q1 | $1.05M | Sell |
7,750
-2,675
| -26% | -$362K | 0.04% | 425 |
|
|
2016
Q4 | $1.5M | Sell |
10,425
-275
| -3% | -$39.4K | 0.06% | 336 |
|
|
2016
Q3 | $1.26M | Buy |
10,700
+4,420
| +70% | +$522K | 0.06% | 338 |
|
|
2016
Q2 | $665K | Buy |
6,280
+5,870
| +1,432% | +$622K | 0.03% | 383 |
|
|
2016
Q1 | $44K | Buy |
+410
| New | +$44K | ﹤0.01% | 438 |
|